Department of Biostatistics and Medical Informatics, School of Medicine, Acibadem University, Istanbul, Turkey.
Department of Neurosurgery, School of Medicine, Acibadem University, 34752, Istanbul, Turkey.
Acta Neuropathol Commun. 2024 Jun 14;12(1):95. doi: 10.1186/s40478-024-01811-1.
MYC dysregulation is pivotal in the onset and progression of IDH-mutant gliomas, mostly driven by copy-number alterations, regulatory element alterations, or epigenetic changes. Our pilot analysis uncovered instances of relative MYC overexpression without alterations in the proximal MYC network (PMN), prompting a deeper investigation into potential novel oncogenic mechanisms. Analysing comprehensive genomics profiles of 236 "IDH-mutant 1p/19q non-co-deleted" lower-grade gliomas from The Cancer Genome Atlas, we identified somatic genomic alterations within the PMN. In tumours without PMN-alterations but with MYC-overexpression, genes correlated with MYC-overexpression were identified. Our analyses yielded that 86/236 of astrocytomas exhibited no PMN-alterations, a subset of 21/86 displaying relative MYC overexpression. Within this subset, we discovered 42 genes inversely correlated with relative MYC expression, all on 19q. Further analysis pinpointed a minimal common region at 19q13.43, encompassing 15 genes. The inverse correlations of these 15 genes with relative MYC overexpression were re-confirmed using independent scRNAseq data. Further, the micro-deleted astrocytoma subset displayed significantly higher genomic instability compared to WT cases, but lower instability compared to PMN-hit cases. This newly identified 19q micro-deletion represents a potential novel mechanism underlying MYC dysregulation in astrocytomas. Given the prominence of 19q loss in IDH-mutant gliomas, our findings bear significant implications for understanding gliomagenesis.
MYC 失调在 IDH 突变型神经胶质瘤的发生和进展中起着关键作用,主要由拷贝数改变、调节元件改变或表观遗传改变驱动。我们的初步分析发现了 MYC 相对过表达而近端 MYC 网络(PMN)无改变的情况,促使我们深入研究潜在的新致癌机制。对来自癌症基因组图谱的 236 例“IDH 突变 1p/19q 非共缺失”低级别神经胶质瘤的综合基因组谱进行分析,我们在 PMN 内鉴定出体细胞基因组改变。在没有 PMN 改变但 MYC 过表达的肿瘤中,鉴定出与 MYC 过表达相关的基因。我们的分析表明,236 例星形细胞瘤中有 86 例没有 PMN 改变,其中 21 例表现为相对 MYC 过表达。在这个亚组中,我们发现了 42 个与相对 MYC 表达呈负相关的基因,全部位于 19q 上。进一步分析确定了 19q13.43 上的一个最小共同区域,包含 15 个基因。使用独立的 scRNAseq 数据重新确认了这 15 个基因与相对 MYC 过表达的负相关。此外,与 WT 病例相比,微缺失星形细胞瘤亚组的基因组不稳定性显著更高,但与 PMN 受累病例相比,其不稳定性更低。这种新鉴定的 19q 微缺失代表了星形细胞瘤中 MYC 失调的潜在新机制。鉴于 IDH 突变型神经胶质瘤中 19q 缺失的突出性,我们的发现对理解神经胶质瘤发生具有重要意义。